Biogen Idec (BIIB) led a handful of Spotlight stocks to new highs Friday as the market rallied. Biogen blasted about 10% in huge volume after the company reported better-than-expected results for its much-anticipated treatment for Alzheimer’s disease. Like just about all of the 16 Spotlight stocks, Biogen has risen well out of buying range.